{"id":59814,"date":"2022-02-08T17:17:15","date_gmt":"2022-02-08T13:17:15","guid":{"rendered":"https:\/\/noortrends.ae\/en\/?p=59814"},"modified":"2022-02-08T17:17:17","modified_gmt":"2022-02-08T13:17:17","slug":"pfizer-expects-54-billion-in-2022-sales-on-covid-vaccine","status":"publish","type":"post","link":"https:\/\/noortrends.ae\/en\/pfizer-expects-54-billion-in-2022-sales-on-covid-vaccine\/02\/08\/market-updates\/","title":{"rendered":"Pfizer Expects $54 Billion in 2022 Sales on Covid Vaccine"},"content":{"rendered":"\n<p>Pfizer Inc. recorded quarterly profits above analysts&#8217; expectations, and its revenues rose, but less than estimates, while it expects to record strong sales of its vaccine and treatment for the Coronavirus.<\/p>\n\n\n\n<p>Pfizer\u2019s fourth-quarter revenue more than doubled overall to $23.84 billion year-over-year, driven by $12.5 billion in sales of its Covid vaccine<\/p>\n\n\n\n<p>Pfizer\u2019s miss on revenue was driven by lackluster sales in its internal medicine and hospital segments. Fourth-quarter internal medicine sales fell 3% year-over-year to $2.24 billion, while hospital sales were largely flat at $1.88 billion compared to the same quarter in 2020. Pfizer\u2019s oncology sales grew 7% to $3.24 billion compared with the same three months in the previous year.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Inc. recorded quarterly profits above analysts&#8217; expectations, and its revenues rose, but less than estimates, while it expects to record strong sales of its vaccine and treatment for the Coronavirus. Pfizer\u2019s fourth-quarter revenue more than doubled overall to $23.84 billion year-over-year, driven by $12.5 billion in sales of its Covid vaccine Pfizer\u2019s miss on &hellip;<\/p>\n","protected":false},"author":9,"featured_media":48869,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39,36],"tags":[8166,7410,6879,8236],"class_list":["post-59814","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-global-stock-markets","category-market-updates","tag-omicron","tag-pfizer","tag-shares","tag-vaccines"],"_links":{"self":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/59814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/comments?post=59814"}],"version-history":[{"count":1,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/59814\/revisions"}],"predecessor-version":[{"id":59815,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/59814\/revisions\/59815"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media\/48869"}],"wp:attachment":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media?parent=59814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/categories?post=59814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/tags?post=59814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}